Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 18Lymphoma, Non-Hodgkin 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hodgkin Disease 11Lymphoma, Large B-Cell, Diffuse 9Central Nervous System Neoplasms 9Leukemia, Myeloid, Acute 8Neuroblastoma 7Multiple Myeloma 7Leukemia 7Brain Neoplasms 7Small Cell Lung Carcinoma 6Sarcoma 6Lymphoma, Large-Cell, Immunoblastic 6Lymphoma, Mantle-Cell 5Lymphoma, Follicular 5Leukemia, Lymphocytic, Chronic, B-Cell 5Lymphoma, B-Cell, Marginal Zone 4Carcinoma, Non-Small-Cell Lung 4Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Rhabdoid Tumor 3Medulloblastoma 3Lung Neoplasms 3Astrocytoma 3Waldenstrom Macroglobulinemia 2Testicular Germ Cell Tumor 2Rhabdomyosarcoma 2Recurrence 2

Interventions

mogamulizumab 4Lenalidomide 3Cyclophosphamide 3Alemtuzumab 2peginterferon alfa-2b 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1cobomarsen 1belinostat 1Zidovudine 1Vincristine 1Raltegravir Potassium 1Prednisone 1Oxaliplatin 1Introns 1Interleukin-15 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cytarabine 1Cisplatin 1Calcium Dobesilate 1Bortezomib 1B3(Fv)-PE38KDEL recombinant immunotoxin 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia-Lymphoma, Adult T-Cell × etoposide phosphate × Clear all
NCT01000285 2017-03-28

ATLL

Washington University School of Medicine

Phase 1/2 Completed
18 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡